At the annual general meeting (AGM) on May 7, 2014, of Meda AB (publ), corporate
ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of 2,50
SEK per share.
The AGM adopted balance sheets and income statements and discharged the members
of the board and the CEO from liability for the fiscal year 2013.
The board was elected according to the nomination committee´s revised proposal.
The nomination committee’s proposal for remuneration to the board and the
auditors was adopted.
The AGM authorized the board to make decisions on the issue of shares, and on
buying and selling Meda shares.
The AGM resolved on the implementation of a long-term performance-based
Details of the AGM resolutions are available at Meda’s head office at pipers väg
2A, Solna Sweden, or by calling +46 8 630 1900. They will be sent on request
free of charge to shareholders who provide an address.
For further inquiries, please contact:
Paula Treutiger, Investor
ph: +46 733-666 599
MEDA AB (publ) is a leading international specialty pharma company. Meda’s
products are sold in more than 120 countries worldwide and the company is
represented by its own organizations in close to 60 countries. The Meda share is
listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm.
Find out more, visit www.meda.se.
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454